Category: Uncategorized

KAILERA’S ORAL GLP-1 BREAKTHROUGH: THE NEXT CHAPTER OF THE GLOBAL OBESITY DRUG RACE

08/07/2026 Published by PhamTuThu

Key Development The global obesity drug market is entering a new phase as Kailera Therapeutics’ oral GLP-1 candidate HRS-7535 (KAI-7535)... Read more

Tags: #Global Trends

ASTRAZENECA’S $1.9B CHINA BET: WHY RESPIRATORY INNOVATION IS BECOMING BIG PHARMA’S NEXT BATTLEGROUND

08/07/2026 Published by PhamTuThu

Key Development AstraZeneca has expanded its strategic partnership with China’s pharmaceutical sector through a licensing agreement with Sino Biopharmaceutical worth... Read more

Category: Uncategorized

VERTEX’S $10 BILLION BET ON CRINETICS SIGNALS THE NEXT PHASE OF RARE DISEASE CONSOLIDATION

08/07/2026 Published by PhamTuThu

Key Development Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a transaction valued at approximately US$10 billion, marking one... Read more

Category: Uncategorized

Europe Moves Bispecific Antibodies Earlier in Follicular Lymphoma Care as AbbVie Secures New Regulatory Milestone

07/07/2026 Published by PhamTuThu

Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more

Category: Uncategorized

Post-Pandemic Restructuring: BioNTech Executes Confidential Divestment Talks Over 4 German Manufacturing Sites to Fund Oncology Pivot

06/07/2026 Published by Pharma Biz

Key Development German biotechnology pioneer BioNTech SE—the co-developer of the blockbuster Comirnaty mRNA COVID-19 vaccine—has initiated highly confidential discussions with... Read more

Category: Uncategorized

Tags: #M&A

Blockbuster ADC Consolidation: Novartis Deploys $1.5 Billion to Acquire Myricx Bio, Securing Next-Gen Payload Platforms to Overcome Tumor Resistance

06/07/2026 Published by Pharma Biz

Key Development Swiss pharmaceutical major Novartis has formally entered into a definitive agreement to acquire U.S./U.K.-based biotechnology innovator Myricx Bio... Read more

Category: Uncategorized

Tags: #M&A

More Than a New Therapy: Vietnam’s Hyperkalemia Breakthrough Reshapes Cardiorenal Care

06/07/2026 Published by PhamTuThu

Executive Summary Vietnam has expanded access to sodium zirconium cyclosilicate (SZC), a next-generation oral potassium binder for hyperkalemia, through the... Read more

Category: Uncategorized

Tags: #Vietnam